0001415889-24-010291.txt : 20240404
0001415889-24-010291.hdr.sgml : 20240404
20240404164531
ACCESSION NUMBER: 0001415889-24-010291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240402
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH PATRICK F
CENTRAL INDEX KEY: 0001890360
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39799
FILM NUMBER: 24823685
MAIL ADDRESS:
STREET 1: C/O CERTARA, INC.
STREET 2: 100 OVERLOOK CENTER, SUITE 101
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Certara, Inc.
CENTRAL INDEX KEY: 0001827090
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
ORGANIZATION NAME: 06 Technology
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 OVERLOOK CENTER, SUITE 101
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: (609) 716-7900
MAIL ADDRESS:
STREET 1: 100 OVERLOOK CENTER, SUITE 101
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
form4-04042024_080424.xml
X0508
4
2024-04-02
0001827090
Certara, Inc.
CERT
0001890360
SMITH PATRICK F
C/O CERTARA, INC.
100 OVERLOOK CENTER, SUITE 101
PRINCETON
NJ
08540
false
true
false
false
PRESIDENT, DRUG DEV SOLUTIONS
1
Common Stock
2024-04-02
4
S
0
5264
16.76
D
59254
D
Common Stock
2024-04-02
4
S
0
649
17.72
D
58605
D
Common Stock
2024-04-02
4
S
0
3024
16.75
D
55581
D
Common Stock
2024-04-02
4
S
0
328
17.67
D
55253
D
Common Stock
2024-04-02
4
S
0
4740
16.77
D
50513
D
Common Stock
2024-04-02
4
S
0
422
17.77
D
50091
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2023.
This transaction was executed in multiple trades at prices ranging from $16.50 to $16.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $17.53 to $17.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $16.49 to $16.96. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $17.53 to $17.74. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $16.50 to $17.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $17.70 to $17.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Richard M. Traynor, as Attorney-in-Fact for Patrick F. Smith
2024-04-04